Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-28

Clinical Trial Update: Study to Evaluate Efficacy and Safety of Oral Doses of Hyoscine Butylbromide for the Treatment of Occasional Abdominal Pain, Cramping, and Discomfort [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oral hyoscine butylbromide for occasional abdominal pain in colic has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hyoscine Butylbromide (hyoscine butylbromide)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Colic | Phase 2 | Status: COMPLETED